ScholarSpace will be down for maintenance on Friday (11/23) from 10AM to 12PM HST. Please contact sspace@hawaii.edu with questions.
Please use this identifier to cite or link to this item: http://hdl.handle.net/10125/33662

Neuromodulation by a N-Terminal Beta Amyloid Fragment

File Size Format  
Minezaki_Anne_Senior_Honors_Thesis.pdf 1.13 MB Adobe PDF View/Open

Item Summary

Title:Neuromodulation by a N-Terminal Beta Amyloid Fragment
Authors:Minezaki, Anne
Contributors:Nichols, Robert (advisor)
Biology (department)
Keywords:beta amyloid (Aβ)
N-terminal Aβ fragment (Aβ1-15)
secretase
Date Issued:26 Sep 2014
Publisher:University of Hawaii at Manoa
Abstract:Beta amyloid (Aβ), a polypeptide found in the brain consisting of 38-43 amino acids, is generated via proteolytic cleavage of amyloid precursor protein (APP). Although multiple isoforms of Aβ exist, the 1-42 amino acid isoform (Aβ1-42) has been found to be the primary neurotoxic species in Alzheimer’s disease, formed via cleavage of APP by β-secretase and γ-secretase. However, it has been shown that a non-amyloidogenic pathway exists wherein Aβ is cleaved by another protease, α-secretase, ultimately resulting in the generation of a 1-15 amino acid fragment, termed the N-terminal Aβ fragment (Aβ1-15). It has shown that inhibition of γ-secretase leads to upregulation of α-secretase activity, possibly leading to increased levels of the N-terminal Aβ fragment. More intriguingly, the Aβ1-15 fragment may function as a potent non-toxic, neuromodulator. Thus, I am investigating: (1) the pathways involved in the regulation of production of the N-terminal beta amyloid fragment with a particular focus on the alpha secretase pathway and its potential modulation by regulators of alpha secretase activity and (2) whether the upregulation of the N-terminal beta amyloid fragment in culture is neuroprotective and/or neuromodulatory. Using immunoblot analysis, we have shown production of APP in FLAG-tagged APP-transfected neuroblastoma cells. In addition, preliminary results suggest that treatment with the γ-secretase inhibitor DAPT leads to greater processing of APP and possible generation of Aβ1-15. We anticipate the Aβ1-15 activity to lead to neuromodulation of nerve cell function.
Pages/Duration:iv, 35 pages
URI/DOI:http://hdl.handle.net/10125/33662
Rights:All UHM Honors Projects are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission from the copyright owner.
Appears in Collections: Honors Projects for Biology


Please email libraryada-l@lists.hawaii.edu if you need this content in ADA-compliant format.

Items in ScholarSpace are protected by copyright, with all rights reserved, unless otherwise indicated.